$8.81
-1.2%Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Administrative Manager
Chief Legal & Compliance Officer and Corporate Secretary
Compensation
$564,703
Chief Operating Officer & Chief Financial Officer
Compensation
$810,651
Chief Scientific Officer
Compensation
$476,992
Head of Investor Relations
President, Chief Executive Officer & Director
Compensation
$1,221,352
Vice President, Corporate Controller & Chief Accounting Officer
During the last 12 months, insiders have purchased $3K worth of NEOG shares, with no selling activity reported.
0
0.00
0
0.00
+0
+$0
209
2.01K
0
0.00
+2K
+$2K
177
1.11K
0
0.00
+1K
+$1K
0
0.00
0
0.00
+0
+$0
Nassif Mikheal
Director, Officer: Ceo
$3K
No selling activity
Strong bullish signal with $3K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Perfect buy/sell ratio. Only buying activity with zero sellingโthe most bullish possible insider signal.
1 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Unanimous insider buying: Zero selling combined with active buying is rare and typically very bullish. Insiders appear to see significant upside with limited downside risk.
NEOG - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | September 12, 2025 | September 12, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | September 13, 2024 | October 24, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | September 18, 2023 | October 25, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | August 30, 2022 | October 06, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | August 31, 2021 | October 07, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | August 31, 2020 | October 08, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | August 27, 2019 | October 03, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | August 28, 2018 | October 04, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | August 30, 2017 | October 05, 2017 | 2017 | |
DEF 14A DEF 14A 2016 N/A | August 31, 2016 | October 06, 2016 | 2016 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.